Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Go back to Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
(NASDAQ: CRDF) Delayed: 1.37 --0 (-0%)
Previous Close $1.37    52 Week High
Open $1.37    52 Week Low
Day High $1.37    P/E N/A 
Day Low $1.37    EPS
Volume 434